MétaCan
← tous les travaux

Periocular sebaceous gland carcinoma: do androgen receptor (<scp>NR</scp>3<scp>C</scp>4) and nuclear survivin (<scp>BIRC</scp>5) have a prognostic significance?

2014· article· en· 24 citations· W2142752305 sur OpenAlex· 10.1111/aos.12466

Pourquoi ce travail est-il dans la base ?

Une base qui oublie comment elle a trouvé un travail ne peut pas être vérifiée. Voici les voies qui ont admis celui-ci.

Affiliation canadienneUne personne signataire a déclaré un établissement canadien. C'est la seule voie dont dispose la base habituelle.

Le tri à trois modèles

les 1 000 travaux triés →

Les trois modèles l'ont jugé hors champ.

strate : aff_core · poids de sondage : 5595.24 (l'échantillon est stratifié ; tout taux calculé sans le poids est faux)
Claude Opus 4.8OUT
genre : empirical
porte sur le Canada: non
confiance: high

Immunohistochemical biomarker study in sebaceous gland carcinoma; clinical pathology.

GPT-5.6 (high)OUT
genre : empirical
porte sur le Canada: non
confiance: high

This studies prognostic markers in carcinoma, not research practice.

Grok 4.5OUT
genre : empirical
porte sur le Canada: non
confiance: high

Clinical oncology study of prognostic markers in periocular sebaceous carcinoma.

Résumé

PURPOSE: The study aimed at evaluating the expression of androgen receptor (AR) and nuclear survivin (NS) in periocular sebaceous gland carcinoma (SGC) and to determine whether this expression is associated with histopathological features, markers of apoptosis and proliferation and with clinical outcomes. METHODS: This was a retrospective, comparative case series which included 56 patients with a biopsy-proven periocular SGC. Immunohistochemical staining for AR, survivin, p53 and Ki-67 was analysed in all cases. RESULTS: All patients expressed AR, p53 and Ki-67 in the nucleus of tumour cells. Twenty-four patients (42.8%) had a high AR score, and 32 patients (57.2%) had a low AR score. Twenty-four (42.8%) patients expressed survivin in the nucleus of tumour cells. Nine (37.5%) had a high NS score, and 15 (62.5%) had a low NS score. Patients with a high AR score had a greater recurrence (p < 0.005), higher expression of Ki-67 (p < 0.0001) and a lower p53 expression (p < 0.005). Nuclear expression of survivin correlated with a high Ki-67 labelling index (0.0001) and low p53 expression (<0.005). Neither nuclear expression of survivin nor the NS score correlated with any clinicopathological features. CONCLUSION: Expression of AR significantly impacts prognosis and is thus promising prognostic marker in periocular SGC.

Conservé avec la notice de tri, où il sert de preuve aux étiquettes ci-dessus.

La notice

Revue
Acta Ophthalmologica
Thématique
Nonmelanoma Skin Cancer Studies
Domaine
Medicine
Établissements canadiens
Vancouver General HospitalUniversity of British Columbia
Organismes subventionnaires
Hyderabad Eye Research Foundation
Mots-clés
SurvivinImmunohistochemistryAndrogen receptorMedicineApoptosisCancer researchPathologyCarcinomaBiopsyInternal medicineOncologyBiologyCancer
Résumé présent dans OpenAlex
oui